Lonza Group AG
LONN
Rang in Aktien
#444
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Aktienkurs
$764.04
Marktkapitalisierung
$53.36B
Veränderung (1 Tag)
0.96%
Veränderung (1 Jahr)
8.59%
Land
CH
Handel Lonza Group AG (LONN)
Kategorie
Healthcare
Kursverlauf für Lonza Group AG (LONN)
Höchster Schlusskurs: $758.59 am 2026-10-01
Niedrigster Schlusskurs: $55.45 am 1999-11-01
Niedrigster Schlusskurs: $55.45 am 1999-11-01
Kursverlauf der Aktie von Lonza Group AG von 1999 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | 2.71% |
| 2025 | 12.69% |
| 2024 | 52.26% |
| 2023 | -21.39% |
| 2022 | -38.27% |
| 2021 | 29.85% |
| 2020 | 78.48% |
| 2019 | 17.36% |
| 2018 | 12.75% |
| 2017 | 66.47% |
| 2016 | 7.54% |
| 2015 | 39.65% |
| 2014 | 24.10% |
| 2013 | 74.91% |
| 2012 | -11.33% |
| 2011 | -26.82% |
| 2010 | 12.01% |
| 2009 | -13.00% |
| 2008 | -29.50% |
| 2007 | 34.20% |
| 2006 | 46.37% |
| 2005 | 8.46% |
| 2004 | 5.02% |
| 2003 | -11.00% |
| 2002 | -13.66% |
| 2001 | 22.46% |
| 2000 | -6.51% |
| 1999 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $533.96 | 25.21% |
US
|
|
| $232.80 | 767.04% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $882.27 | 8.36% |
NL
|
|
| $290.30 | 1.99% |
BE
|
